Literature DB >> 15922942

PTX cruiser: driving autoimmunity via TLR4.

Michael K Racke1, Wei Hu, Amy E Lovett-Racke.   

Abstract

Although the cause of autoimmune diseases is unknown, it has long been speculated that an infectious agent might have a role in their initiation and progression. Experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), has been used to study factors in disease pathogenesis. A recent study shows that pertussis toxin, which is used as an adjuvant in EAE, uses Toll-like receptor 4 signaling to mediate its disease-inducing effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922942     DOI: 10.1016/j.it.2005.03.012

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  29 in total

1.  Anaphylaxis and mortality induced by treatment of mice with anti-VLA-4 antibody and pertussis toxin.

Authors:  Niannian Ji; Nagarjun Rao; Neal M Guentzel; Bernard P Arulanandam; Thomas G Forsthuber
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

2.  Trichuris suis soluble products induce Rab7b expression and limit TLR4 responses in human dendritic cells.

Authors:  E J Klaver; T C T M van der Pouw Kraan; L C Laan; H Kringel; R D Cummings; G Bouma; G Kraal; I van Die
Journal:  Genes Immun       Date:  2015-05-21       Impact factor: 2.676

3.  Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose.

Authors:  Lili Hu; Hongxia Yang; Ming Ai; Shuanghong Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-14       Impact factor: 3.117

4.  Selective protection of murine cerebral Gi/o-proteins from inactivation by parenterally injected pertussis toxin.

Authors:  Salvador Castaneda Vega; Veronika Leiss; Roland Piekorz; Carsten Calaminus; Katja Pexa; Marta Vuozzo; Andreas M Schmid; Vasudharani Devanathan; Christian Kesenheimer; Bernd J Pichler; Sandra Beer-Hammer; Bernd Nürnberg
Journal:  J Mol Med (Berl)       Date:  2019-12-06       Impact factor: 4.599

5.  Role of toll-like receptors in multiple sclerosis.

Authors:  Socorro Miranda-Hernandez; Alan G Baxter
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

6.  Pertussis toxin up-regulates angiotensin type 1 receptors through Toll-like receptor 4-mediated Rac activation.

Authors:  Motohiro Nishida; Reiko Suda; Yuichi Nagamatsu; Shihori Tanabe; Naoya Onohara; Michio Nakaya; Yasunori Kanaho; Takahiro Shibata; Koji Uchida; Hideki Sumimoto; Yoji Sato; Hitoshi Kurose
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

7.  Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response.

Authors:  Yuxiang Rui; Tasuku Honjo; Shunsuke Chikuma
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  Pertussis Toxin Exploits Specific Host Cell Signaling Pathways for Promoting Invasion and Translocation of Escherichia coli K1 RS218 in Human Brain-derived Microvascular Endothelial Cells.

Authors:  Sascha Karassek; Laura Starost; Johanna Solbach; Lilo Greune; Yasuteru Sano; Takashi Kanda; KwangSik Kim; M Alexander Schmidt
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

Review 9.  Toll-like receptors in central nervous system glial inflammation and homeostasis.

Authors:  Tammy Kielian
Journal:  J Neurosci Res       Date:  2006-04       Impact factor: 4.164

10.  Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis.

Authors:  Jihong Xu; Michael K Racke; Paul D Drew
Journal:  J Neurochem       Date:  2007-12       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.